Bank of America Securities Maintains a Buy on CVS Health Corporation (CVS)

Core Insights - CVS Health Corporation (NYSE:CVS) is identified as one of the best large-cap value stocks to buy currently, with a Buy rating maintained by Bank of America Securities analyst Allen Lutz and a price target set at $89.00 [1] Financial Performance - For fiscal Q2 2025, CVS Health reported total revenues of $98.9 billion, reflecting an 8.4% increase compared to the same period last year [2] - The GAAP diluted EPS for the quarter was $0.80, while the adjusted EPS stood at $1.81 [2] - Year-to-date cash flow from operations reached $6.5 billion [2] Business Segments - CVS Health operates in four segments: healthcare benefits, health services, pharmacy & consumer wellness, and corporate/other [3]